Sean Westover, DPM
Foot & Ankle Surgery · Salem, ORNPI 1285080556
Payments from drug & device makers
What this record shows
20 manufacturers reported payments, led by Paragon 28, Inc. at 55.5% of the total. Reporting peaked in 2023 at $1,461 and has fallen 93.4% since, to $96 in 2025.
Across 64 payments — averaging $53.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Paragon 28, Inc.$2K
- Stryker$585
- Smith+Nephew$303
- Steelhead Surgical Inc$227
- Medtronic$70
- Bioventus LLC$44
- plus $306 from 14 others
What the payments were for
- Travel & lodging$1,42241%
- Food & beverage$2,02759%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Paragon 28, Inc. | 9 | $1,914 |
| Stryker | 12 | $585 |
| Smith+Nephew | 16 | $303 |
| Steelhead Surgical Inc | 6 | $227 |
| Medtronic | 2 | $70 |
| Bioventus LLC | 3 | $44 |
| Amgen | 2 | $43 |
| Zimmer Biomet | 2 | $43 |
| Solventum Corporation | 1 | $25 |
| Vertex | 1 | $24 |
| Left Coast Surgical Inc | 1 | $23 |
| Acera Surgical, Inc. | 1 | $23 |
| Mimedx Group, Inc. | 1 | $19 |
| Paratek Pharmaceuticals, Inc. | 1 | $19 |
| AbbVie | 1 | $18 |
| Abbott | 1 | $16 |
| Heron Therapeutics, Inc. | 1 | $15 |
| Advanced Oxygen Therapy Inc. | 1 | $14 |
| KCI USA, Inc. | 1 | $14 |
| Orthofix Medical, Inc. | 1 | $10 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Portfolio$1,103
- VARIAX$135
- AUGMENT INJECTABLE$116
How this compares
$3,449 in reported general payments places this provider in the 60th percentile of 113 foot & ankle surgery providers in Oregon.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Gabapentin | 12 | $193 |
| Mupirocin | 12 | $151 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 27 | $122 |
| Cephalexin | 12 | $106 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 11 | $47 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in Salem
- Justin BrohardSalem$24K
- Trevor TippetsSalem$11K
- Brent BeirdneauSalem$10K
- Bryce RichSalem$8K
- Natalie MesnierPortland$339K
- Stephen WallaceLake Oswego$205K
- Scott BoyntonPortland$120K
- Andrew ShinabargerPortland$85K
- Cassandra TomczakTualatin$73K
- Akash GuptaMilwaukie$40K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.